The Detection of Xylazine in Tijuana, Mexico: Triangulating Drug Checking and Clinical Urine Testing Data
Xylazine is present on the US-Mexico border, requiring public health intervention. High lidocaine positivity complicates the clinical detection of xylazine via testing strips. Routine urine testing for xylazine in clinical scenarios is likely feasible, yet confirmatory urine studies are needed.
Authors
- Chelsea L. Shover (ORCID: https://orcid.org/0000-0002-0728-4101)
- Joseph Friedman (ORCID: https://orcid.org/0000-0002-5225-3267)
- Luis A. Segovia
- Morgan Godvin (ORCID: https://orcid.org/0009-0000-5688-3904)
- Lilia Pacheco Bufanda
- Meghan Grace Appley (ORCID: https://orcid.org/0000-0001-9840-6903)
- Edward Sisco (ORCID: https://orcid.org/0000-0003-0252-1910)
- Elise M. Pyfrom (ORCID: https://orcid.org/0009-0004-3305-6446)
- Mariana Alejandra González Tejeda
- Alejando González Montoya
- Carmina Ruiz
Institutions
- Twitter (United States) (US)
- National Institute of Standards and Technology (US)
- University of California, Los Angeles (US)
- School of the Art Institute of Chicago (US)
- Xochicalco University (MX)
- University of California San Diego (US)
Publication Details
- Journal
- Journal of Addiction Medicine
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1097/adm.0000000000001474
- Citations
- 5
- Primary Topic
- Veterinary Pharmacology and Anesthesia
- Type
- article
- Field-Weighted Citation Impact
- 11.77